Carle Ryckman, PhD

· Integral member of the Hematology and Oncology Cross-Functional Leadership team.

· Established vision, strategy and priorities for the Heme/Onc Business Unit and ensured teams performances.

· Implemented a new cross-functional 'Go to Market model' to enhance customer experience and align with evolving business needs.

· Established a medical vision for, led and oversaw the medical affairs and medical education teams in developing and executing medical strategies for the oncology and hematology portfolios.

· Oversaw post-marketing studies, Investigator-sponsored trials, and non-Interventional research initiatives.

· Collaborated with global medical affairs and R&D teams to ensure strategic alignment.

· Provided scientific guidance and strategic expertise to regulatory, market access, marketing, and other local stakeholders on future launches.

· Managed and developed the medical affairs teams, focusing on performance excellence and talent development. Ensured execution excellence through development of clear and focused objectives and KPIs. Identify performance gaps and provide appropriate training and resources to maintain high scientific/technical expertise.

· Integral member of the medical leadership team; Established a vision for the medical organization in accordance with the international strategy that drives scientific product development and commercialization activities.

· Established a vision for, led and oversaw the medical affairs teams in developing and executing medical strategies and activities for the oncology portfolio.

· Executed medically led launches for various indications without commercial support.

· Oversaw post-marketing studies, Investigator-sponsored trials, and Non-Interventional Research activities.

· Collaborated with global medical affairs and R&D teams and local cross-functional teams to ensure strategic alignment.

· Provided scientific guidance and strategic expertise to regulatory, market access, marketing and other local stakeholders on future launches.

· Managed and developed the medical affairs teams, focusing on performance excellence and talent development. Ensured execution excellence through the development of clear and focused objectives and KPIs. Identify performance gaps and provide appropriate training and resources to maintain high scientific/technical expertise.

· Integral member of the medical leadership team.

· Established a vision for the medical organization in accordance with the international strategy that drives scientific product development and commercialization activities.

· Member of Pharma Senior Leadership Team, leading the development of the strategies and operations for the Canadian Pharma Business Unit. (90% of Valeant Canada Revenues).

· Developed vision for, led and oversaw the medical strategy and operations of medical affairs and clinical research teams in CV/Met, Neuroscience and Dermatology.

· Established core competencies development program and therapeutic area training programs.

· Created a new Medical Affairs and clinical research team structure and recruited personnel (MSLs + MSL Manager, Medical advisors, Clinical Program Manager and Clinical trial associates).

· Led the development and execution of brand strategic plans and tactical plans for medical affairs teams.

· Managed performance and execution excellence of medical affairs teams.

· Led the development, execution, and achievement of key milestones of all Canadian-led clinical studies including Phase II to Phase IV, Registries, Queries, retrospective analyses, PPAs, and the Canadian Publication Plan.

· Business Development: Provided Scientific/clinical expertise, support and recommendation in Business Development strategy and opportunities for the Specialty product pipeline.

Recruit and lead a new MSL team and ensure execution of the Canadian medical plans in dermatology and Cardiovascular.

· Integral member of the Global medical team, representing the Intercontinental region.

· Led strategy and provided disease state knowledge for assets relevant to the region.

· Ensured global to market launch readiness and delivery.

· Developed medical and communication plans and facilitated regional medical education events.

· Medical lead co-leading the elaboration of the brand strategic plan, and development of the tactical plan.

· Developed and led the medical strategy and tactical plans for the brand.

· Developed and executed a Phase IV trial.

· Supported the development and implementation of Canadian symposia/CHE/speaker tours.

· Created and led of added value medical education programs during conferences ‘’Medical Passport Program’’

· Provided scientific support to regulatory and access teams.

· Led the development and implementation of the Canadian publication Plan.

· Scientific support and training to MSLs to sales representatives

· Scientific development of Key Opinion leaders in the territory.

· Implemented tactics for the launch of new products in Cardiology and Osteoporosis.

· Developed and implemented symposia and Continuing Health Education (CHE) programs.

· Medical lead and integral member of the for Canadian brand team

· Scientific development of Key Opinion leaders across the country

· Development of strategies and tactics for the launch of new indications

· Support development and implementation of Bayer Canadian symposia and CHE

· Led local ISRs including a phase II in HCC, supported clinical trials and led the Canadian publication plan.

· Scientific support for access both at Head office and in the field for Provincial Listings

· Training to internal stakeholders and sales representatives

· Medical lead and integral member of the for Canadian brand team

· Scientific development of Key Opinion leaders across the country

· Development of strategies and tactics for the launch of new indications

· Support development and implementation of Bayer Canadian symposia and CHE

· Worldwide medical lead for C-difficile outbreaks (2009) were I led the data generation, education and regional support plans.

· Scientific support for access both at Head office and in the field for Provincial Listings

· Training to internal stakeholders and sales representatives

• Immunology specialist and consultant for several research projects
• Team leader for the discovery of a new anti-cancer vaccine

· Conducted scientific analysis of several biotechnology companies for venture capital investments.

· Evaluated pre-clinical and clinical studies, comparing with the competition.

· Assessed product market potential.